Type 2 Diabetes

SEP 9, 2026 · PHASE 2 TRIAL

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

ClinicalTrials.gov

Phase 2 trial with completed enrollment but no results posted; design and primary outcome are specified but efficacy and safety data are not yet reported in this registry record.

SEP 9, 2026 · OBSERVATIONAL STUDY

iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases

ClinicalTrials.gov

This is a clinical trial registry record describing a planned observational study with no results posted; it documents study design and intended outcomes only, not evidence of efficacy or safety.

AUG 7, 2026 · INTERVENTIONAL STUDY

Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D)

ClinicalTrials.gov

This is a completed interventional trial in adolescents with type 2 diabetes testing time-limited eating; no results are posted in this registry record, making it preliminary evidence with outcomes yet to be reported.

AUG 6, 2026 · OBSERVATIONAL STUDY

Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity

ClinicalTrials.gov

Registry record for an observational study with completed enrollment; no results posted, so evidence quality cannot be assessed.

AUG 3, 2026 · PHASE 3 TRIAL

Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide

ClinicalTrials.gov

This is an active Phase 3 RCT registration with no posted results; the study design and planned enrollment are reported but outcomes remain unknown.

JUL 24, 2026 · JOURNAL ARTICLE

The dietary pattern derived by reduced-rank regression in association with novel atherogenic risk factors in patients with type 2 diabetes: a cross-sectional study.

Journal of Diabetes and Metabolic Disorders

Cross-sectional association study showing reduced odds of atherogenic indices with healthy dietary pattern in T2DM, but causality cannot be established and prospective validation is needed.

JUL 15, 2026

Association of hematologic-inflammatory indices and all-cause mortality in adults with type 2 diabetes and hypertension.

Journal of Diabetes and Metabolic Disorders

Prospective cohort analysis with 10-year follow-up demonstrates association between inflammatory markers and mortality in diabetes, with adjusted hazard ratios and consistent findings in subgroups.

JUL 3, 2026 · JOURNAL ARTICLE

Impact of obesity and type 2 diabetes on muscle power, quality, and force-velocity, and their relation to functional capacity.

Journal of Diabetes and Metabolic Disorders

Cross-sectional study demonstrating that obesity and T2D impair normalized muscle power and quality in middle-aged adults, with quantified deficits and functional associations, but lacks a comparator intervention and cannot establish causation.